We serve Chemical Name:3-Bromo-2-fluorobenzoic acid CAS:161957-56-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Bromo-2-fluorobenzoic acid
CAS.NO:161957-56-8
Synonyms:MFCD00665763;Benzoic acid, 3-bromo-2-fluoro-;2-fluoro-3-bromobenzoic acid;3-Bromo-2-fluoro-benzoic acid;3-Bromo-2-fluorobenzoic acid;3-Bromo-2-fluoro benzoic acid
Molecular Formula:C7H4BrFO2
Molecular Weight:219.008
HS Code:2916399090
Physical and Chemical Properties:
Melting point:168 °C
Boiling point:298.2±25.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.583
PSA:37.30000
Exact Mass:217.937866
LogP:2.59
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00665763 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-2-fluoro benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-2-fluoro-benzoic acid Use and application,2-fluoro-3-bromobenzoic acid technical grade,usp/ep/jp grade.
Related News: Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. 3-Bromo-2-fluorobenzoic acid manufacturer The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. 3-Bromo-2-fluorobenzoic acid supplier Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 3-Bromo-2-fluorobenzoic acid vendor Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. 3-Bromo-2-fluorobenzoic acid factory The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.
